Talvey 40 MG in 1 ML Injection

RxCUI
2644464
RxNorm name
Talvey 40 MG in 1 ML Injection
Display name
Talvey 40 MG in 1 ML Injection
Full name
Talvey 40 MG in 1 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761342Talveytalquetamab-tgvs351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TALVEYTALQUETAMABJanssen Biotech, Inc.9001355e-003d-4d4e-b4ce-337e0fd149522025-10-08Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2644464

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
9001355e-003d-4d4e-b4ce-337e0fd14952Talvey 40 MG in 1 ML InjectionPSN5These highlights do not include all the information needed to use TALVEY safely and effectively. See full prescribing information for TALVEY. TALVEY ® (talquetamab-tgvs) injection, for subcutaneous use Initial U.S. Approval: 202320251008
9001355e-003d-4d4e-b4ce-337e0fd149521 ML Talvey 40 MG/ML InjectionSY5These highlights do not include all the information needed to use TALVEY safely and effectively. See full prescribing information for TALVEY. TALVEY ® (talquetamab-tgvs) injection, for subcutaneous use Initial U.S. Approval: 202320251008
9001355e-003d-4d4e-b4ce-337e0fd14952Talvey 40 MG per 1 ML InjectionSY5These highlights do not include all the information needed to use TALVEY safely and effectively. See full prescribing information for TALVEY. TALVEY ® (talquetamab-tgvs) injection, for subcutaneous use Initial U.S. Approval: 202320251008
9001355e-003d-4d4e-b4ce-337e0fd149521 ML talquetamab-tgvs 40 MG/ML Injection [Talvey]SBD5These highlights do not include all the information needed to use TALVEY safely and effectively. See full prescribing information for TALVEY. TALVEY ® (talquetamab-tgvs) injection, for subcutaneous use Initial U.S. Approval: 202320251008